Diosgenin (Universite de Limoges)

N/A

Report date: 2023/03/25 23:47:43

Base Information

Drug NameDiosgenin (Universite de Limoges)
Drug Alias NameN/A
ClassificationNatural product/Extract
Mechanisms of ActionApoptosis inducersTumor protein p53 stimulants
TargetsTumor protein p53
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversite De Limoges
China Registration ClassN/A

Develop Information

Active CompaniesUniversite De Limoges
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A